Our Why

“We are leveraging our cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases.”

Søren Tulstrup, President and CEO

 

Latest news

Stockholm -1.60 HNSA   257.60 SEK
 
08Jan

SEB Nordic Seminar

Copenhagen
12Jan

JPM Week

San Francisco
06Feb

Hansa Biopharma Year-End Report 2019

04Mar

Carnegie Nordic Healthcare Seminar

Stockholm, Sweden

Introduction to Hansa

Søren Tulstrup, President & CEO


Hansa in brief
left-photo-mask

Join Hansa

From our headquarters in Lund, Sweden, we reach around the world. Our dedicated team includes experienced and courageous specialists driven by our purpose to develop lifesaving and life altering therapies for patients living with rare immunological diseases.

Since our founding in 2007, we have worked in cross functional and agile teams. We are gender-balanced, comprise 14 different nationalities and see diversity as an enabler for reaching our corporate objectives. The recruitment of highly motivated, experienced and talented team players supports our development towards a fully integrated global biopharmaceutical company.

Careers